Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Open in API
Filings indexed 992 across all filing types
Latest filing 2023-08-09 Interim / Quarterly Rep…
Country FI Finland
Listing HE BIOBV

About Biohit Oyj

https://www.biohithealthcare.com/en/

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
08083282.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Puolivuosikatsaus' (Half-Year Report) for Biohit Oyj covering the period of January-June 2023. It contains comprehensive financial statements, key performance indicators, management commentary, and operational updates. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it is classified as an Interim/Quarterly Report. H1 2023
2023-08-09 Finnish
BIOHIT-KONSERNIN PUOLIVUOSIKATSAUS 2023
Interim / Quarterly Report Classification · 100% confidence The document is a 'Puolivuosikatsaus' (Half-Year Report) for Biohit Oyj for the period ending June 30, 2023. It contains comprehensive financial statements, key performance indicators, management commentary, and operational updates for the first half of the fiscal year. It is not an announcement of a report, but the report itself, containing substantive financial data. H1 2023
2023-08-09 Finnish
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2023' and contains comprehensive financial statements, key figures, management commentary, and operational updates for the six-month period ending June 30, 2023. It provides substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-09 English
BIOHIT-KONSERNIN PUOLIVUOSIKATSAUS 2023
Interim / Quarterly Report Classification · 100% confidence The document is a 'Puolivuosikatsaus' (Half-Year Report) for Biohit Oyj for the period of January-June 2023. It contains comprehensive financial statements, key performance indicators, management commentary, and outlook for the period. It is a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report. H1 2023
2023-08-09 Finnish
06156145.pdf
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the organization of the Board of Directors of Biohit Oyj, specifically naming the newly elected Chairman of the Board. This falls under the category of announcements concerning changes or organization of the board of directors.
2023-06-15 Finnish
Biohit Oyj:n hallituksen järjestäytyminen
Board/Management Information Classification · 100% confidence The document is a short announcement (1191 characters) regarding the organization of the Board of Directors of Biohit Oyj, specifically the election of a new Chairman. This falls under the category of announcements regarding changes in the company's board of directors.
2023-06-15 Finnish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.